{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:53:41Z","timestamp":1783486421378,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.surg.2012.02.020","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T15:17:10Z","timestamp":1334243830000},"page":"164-172","source":"Crossref","is-referenced-by-count":20,"title":["Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment options"],"prefix":"10.1016","volume":"152","author":[{"given":"Kyle","family":"Zanocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Elaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord","family":"Sturgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2012.02.020_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves disease","volume":"343","author":"Weetman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.02.020_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1530\/eje.0.1510549","article-title":"Impaired health-related quality of life in Graves disease. A prospective study","volume":"151","author":"Elberling","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2012.02.020_bib3","first-page":"3","article-title":"The management of hyperthyroidism due to Graves disease in Europe in 1986: results of an international survey","volume":"285","author":"Glinoer","year":"1987","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"10.1016\/j.surg.2012.02.020_bib4","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.surg.2012.02.020_bib5","series-title":"Designing and conducting cost-effectiveness analyses in medicine and health care","author":"Muennig","year":"2002"},{"key":"10.1016\/j.surg.2012.02.020_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A\u00a0systematic review of drug therapy for Graves hyperthyroidism","volume":"153","author":"Abraham","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2012.02.020_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2265.2004.02152.x","article-title":"Long-term follow-up study of radioiodine treatment of hyperthyroidism","volume":"61","author":"Metso","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2012.02.020_bib8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves hyperthyroidism. The Thyroid Study Group","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.02.020_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jsre.2000.5875","article-title":"The efficacy of thyroidectomy for Graves disease: a meta-analysis","volume":"90","author":"Palit","year":"2000","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.surg.2012.02.020_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00268-004-7529-7","article-title":"A\u00a0prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for Graves disease","volume":"29","author":"Chi","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2012.02.020_bib11","series-title":"Red Book","year":"2005"},{"key":"10.1016\/j.surg.2012.02.020_bib12","series-title":"Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine","author":"Petitti","year":"2000"},{"key":"10.1016\/j.surg.2012.02.020_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9681(81)90063-1","article-title":"The \u201cabnormal\u201d screening serum thyroxine (T4): analysis of physician response, outcome, cost and health effectiveness","volume":"34","author":"Epstein","year":"1981","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.surg.2012.02.020_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1530\/eje.1.02029","article-title":"Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis","volume":"153","author":"Sejean","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2012.02.020_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.02.020_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198008073030603","article-title":"Carbimazole and the autoimmune response in Graves disease","volume":"303","author":"McGregor","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2012.02.020_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1016\/j.surg.2012.02.020_bib18","first-page":"104","article-title":"The current status of radioiodine therapy for benign thyroid disorders","volume":"7","author":"van Isselt","year":"2004","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.surg.2012.02.020_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/thy.1998.8.653","article-title":"Quality of life aspects and costs in treatment of Graves hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study","volume":"8","author":"Ljunggren","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2012.02.020_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0950-351X(97)80798-7","article-title":"Treatment of Graves disease: the American way","volume":"11","author":"Levy","year":"1997","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2012.02.020_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.273.10.808","article-title":"Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association","volume":"273","author":"Singer","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2012.02.020_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.suc.2004.01.006","article-title":"Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism","volume":"84","author":"Boger","year":"2004","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.surg.2012.02.020_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0889-8529(05)70134-1","article-title":"Treatment of Graves disease: the advantages of surgery","volume":"29","author":"Alsanea","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.surg.2012.02.020_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jamcollsurg.2009.03.025","article-title":"Treatment options for Graves disease: a cost-effectiveness analysis","volume":"209","author":"In","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.surg.2012.02.020_bib25","first-page":"455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","author":"Sheng","year":"1999","journal-title":"Q\u00a0J M"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606012000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606012000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T23:59:18Z","timestamp":1543017558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606012000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0039606012000621"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2012.02.020","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}